Trademarkia Logo

Australia

AU$
BRIVZO
Accepted: Opposition period expired

Last updated on 13 Aug 2024

Owner Info

Neurotech Pharmaceuticals, Inc.

900 Highland Corporate Drive, Suite 101

Cumberland RI 02864, UNITED STATES OF AMERICA

Serial Number

2454191 filed on 18 Mar 2024

Correspondent

Emilia F. Cannella Ropes & Gray LLP

Prudential Tower,,

800 Boylston Street,

UNITED STATES OF AMERICA

BRIVZO

Classification Information


Class [005]
Intravitreal implants containing a pharmaceutical for the treatment of eye and vision conditions.

Class [010]
Medical device, namely, intraocular implant.

Mark Details


Serial Number

2454191

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

18 Sept 2023

Mark Type

US

Legal History


Show more

Status DateAction Taken
13th Aug 2024International Registration in Australia Protected correspondence sent
12th Aug 2024International Registration in Australia Protected correspondence sent
12th Aug 2024IP Right Registration Published
12th Aug 2024Status change to Registered/Protected
1st Jul 2024Customer Amendment Made correspondence sent
1st Jul 2024Amendment to Address for Service Requested
4th Jun 2024Application Accepted correspondence sent
3rd Jun 2024IP Right has been Examined
3rd Jun 2024IP Right Acceptance Published
3rd Jun 2024Status change to Accepted